Diabetes affects over 40 million Americans, straining healthcare systems with its $412 billion annual burden. In response, CCS and SweetSpot announced a strategic partnership today, launching a pilot program in early 2026 across select U.S. markets to deliver remote monitoring and support, bridging critical gaps in chronic disease management and improving outcomes without overwhelming providers.
Addressing Gaps in Diabetes Management
Traditional diabetes care ends at clinic doors, leaving patients vulnerable between visits. Most practices lack tools for proactive monitoring, as noted by CCS CEO Tony Vahedian: “Diabetes care doesn’t stop when patients leave the clinic, but most practices lack the tools and bandwidth to proactively monitor who needs help.” This partnership integrates SweetSpot’s continuous glucose monitoring (CGM) insights and virtual Certified Diabetes Care and Education Specialists (CDCES) into CCS’s chronic care ecosystem, including its AI-driven PropheSee™ platform for predicting nonadherence.
- SweetSpot handles monthly CGM data reviews, personalized feedback, and virtual education.
- CCS provides home-delivered supplies and established provider relationships.
- The combo targets endocrinology clinics, enhancing workflows and patient adherence.
The Scale of America's Diabetes Challenge
With diabetes impacting 40 million and chronic conditions affecting 133 million Americans, preventable complications drive up costs through hospitalizations and poor glycemic control. Remote care solutions like this pilot align with broader trends in value-based healthcare, where digital tools reduce provider burnout and boost HEDIS scores. Expert analyses show CGM use can lower A1C levels by 0.5-1%, cutting risks of heart disease and kidney failure—key factors in the epidemic fueled by aging populations, obesity, and sedentary lifestyles.
Implications for Providers and Patients
SweetSpot CEO Stephen Von Rump emphasizes scalability: “Partnering with CCS allows us to deliver even greater impact and address one of the biggest gaps in chronic disease management: what happens between appointments.” For providers, automated reimbursable events optimize revenue via CPT codes; for patients, real-time interventions prevent crises. This evolution positions CCS as a holistic chronic care partner, potentially scalable nationwide, amid rising demand for telehealth post-pandemic. Early results could redefine preventive care, easing the burden on an overstretched system and empowering 200,000+ annual CCS patients.
